Iterum Therapeutics (ITRM)
NASDAQ: ITRM
· Real-Time Price · USD
0.76
-0.07 (-8.52%)
At close: Aug 20, 2025, 3:40 PM
0.79
4.00%
After-hours: Aug 20, 2025, 04:10 PM EDT
Iterum Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 13.03M | 12.65M | 24.13M | 13.41M | 4.98M | 7.39M | 6.07M | 4.82M | 13.73M | 16.83M | 21.09M | 20.49M | 9.21M | 31.36M | 27.45M | 35.98M | 36.57M | 66.64M |
Short-Term Investments | n/a | n/a | n/a | 1.1M | 6.74M | 10.82M | 17.86M | 31.08M | 31M | 34.99M | 39.75M | 43.87M | 59.7M | 43.91M | 53.94M | 52.02M | 57.16M | 33.87M |
Long-Term Investments | 34K | n/a | n/a | n/a | 34K | 34K | 34K | 34K | 34K | 34K | -35K | 34K | 34K | 64K | -37K | 64K | 64K | 70K |
Other Long-Term Assets | 19K | 40K | 39K | 40K | 763K | 29K | 29K | 710K | 2.44M | 2.52M | 4.21M | 2.72M | 3.14M | 4.55M | 10.16M | 8.01M | 9.38M | 10.47M |
Receivables | 80K | 19K | 66K | n/a | 195K | 18K | 233K | 170K | 127K | 308K | n/a | 795K | 592K | 413K | 1.21M | 1.03M | 994K | 806K |
Inventory | 948K | 533K | n/a | n/a | n/a | n/a | n/a | n/a | -127K | -308K | -1.85M | n/a | n/a | n/a | -1.21M | n/a | n/a | n/a |
Other Current Assets | n/a | 19K | 65K | 538K | n/a | n/a | n/a | n/a | 2.92M | 2.42M | n/a | 30K | 30K | n/a | 37K | 45K | 67K | 30K |
Total Current Assets | 14.89M | 13.51M | 24.79M | 15.85M | 12.96M | 19.05M | 25.6M | 38.53M | 47.65M | 54.25M | 60.84M | 66.65M | 70.93M | 76.38M | 81.34M | 90.21M | 96.4M | 104.23M |
Property-Plant & Equipment | 12K | 18K | 23K | 30K | 416K | 508K | 600K | 59K | 69K | 62K | 69K | 34K | 46K | 62K | 91K | 138K | 202K | 387K |
Goodwill & Intangibles | 19.06M | 19.4M | 19.75M | n/a | n/a | n/a | n/a | 432K | 861K | 1.29M | 1.72M | 2.15M | 2.58M | 3.01M | 3.44M | n/a | n/a | n/a |
Total Long-Term Assets | 19.12M | 19.46M | 19.81M | 70K | 1.21M | 571K | 663K | 1.2M | 3.37M | 3.87M | 6M | 4.9M | 5.76M | 7.68M | 10.16M | 8.21M | 9.65M | 10.93M |
Total Assets | 34.01M | 32.98M | 44.59M | 15.92M | 14.17M | 19.63M | 26.26M | 39.73M | 51.02M | 58.12M | 66.83M | 71.56M | 76.69M | 84.06M | 91.51M | 98.42M | 106.05M | 115.17M |
Account Payables | 1.19M | 413K | 251K | 835K | 822K | 2.97M | 5M | 5.51M | 3.71M | 2.23M | 2.77M | 1.23M | 787K | 684K | 878K | 276K | 1.94M | 1.85M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 11K | n/a | -314K | -348K | -341K | -332K | -305K | -292K | -475K | -2.5M | 1.83M | 1.27M | 2.24M |
Short-Term Debt | 190K | 124K | 14.46M | 13.71M | 13.31M | 12.57M | n/a | 314K | n/a | n/a | n/a | n/a | n/a | n/a | 1.63M | 3.24M | 5.04M | 6.62M |
Other Current Liabilities | 3.54M | 201K | 240K | 668K | 1.3M | 1.11M | 761K | 8.41M | 5.71M | 4.68M | 1.94M | 4.7M | 3.66M | 6.78M | 9.05M | 12.48M | 26.13M | 33.1M |
Total Current Liabilities | 5.53M | 3.63M | 17.61M | 18.7M | 16.77M | 17.79M | 13.52M | 16.4M | 10.83M | 7.8M | 196K | 7.51M | 7.49M | 10.08M | 6.06M | 17.83M | 34.38M | 43.81M |
Long-Term Debt | 32.37M | 31.9M | 31.07M | 8.73M | 8.3M | 7.89M | 18.96M | 19.59M | 31.92M | 30.14M | 28.47M | 30.21M | 23.57M | 22.11M | 24.9M | 24.54M | 20.65M | 34.89M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.24M | 3.44M | 3.61M | 3.82M | 4.95M |
Total Long-Term Liabilities | 32.37M | 31.9M | 31.07M | 8.73M | 8.31M | 7.98M | 19.14M | 19.9M | 33.06M | 31.37M | 38.64M | 31.5M | 25.31M | 25.35M | 35.22M | 28.14M | 24.47M | 39.84M |
Total Liabilities | 37.9M | 35.53M | 48.68M | 27.43M | 25.09M | 25.77M | 32.66M | 36.3M | 43.89M | 39.16M | 38.83M | 39.01M | 32.8M | 35.43M | 41.27M | 45.97M | 58.85M | 83.65M |
Total Debt | 32.56M | 32.02M | 45.53M | 22.44M | 21.62M | 20.55M | 19.51M | 19.59M | 31.92M | 30.14M | 28.47M | 30.21M | 23.57M | 22.11M | 24.9M | 27.78M | 25.69M | 41.51M |
Common Stock | 421K | 357K | 315K | 227K | 166K | 165K | 135K | 130K | 130K | 128K | 126K | 122K | 1.83M | 1.83M | 1.83M | 1.83M | 1.83M | 1.79M |
Retained Earnings | -497.47M | -490.96M | -486.07M | -479.49M | -473.4M | -468.4M | -461.3M | -448.94M | -445.06M | -432.82M | -422.93M | -417.84M | -388.73M | -381.99M | -378.49M | -374.31M | -378.05M | -385.85M |
Comprehensive Income | n/a | n/a | n/a | 2K | -1K | n/a | 1K | 3K | -26K | -131K | -350K | n/a | n/a | n/a | n/a | -0.00 | n/a | 0.00 |
Shareholders Equity | -3.89M | -2.55M | -4.08M | -11.51M | -10.91M | -6.15M | -6.4M | 3.43M | 7.13M | 18.96M | 28M | 32.55M | 43.89M | 48.63M | 50.23M | 52.45M | 47.2M | 31.52M |
Total Investments | 34K | n/a | n/a | 1.1M | 6.78M | 10.86M | 17.89M | 31.08M | 31M | 34.99M | 39.71M | 43.87M | 59.7M | 43.91M | 53.9M | 52.02M | 57.16M | 33.87M |